Literature DB >> 16792511

Simple procedure for automatic detection of unstable alleles in the myotonic dystrophy and Huntington's disease loci.

M Falk1, M Vojtísková, Z Lukás, I Kroupová, U Froster.   

Abstract

Human neurodegenerative and neuromuscular disorders are associated with a class of gene mutations represented by expansion of trinucleotide repeats. DNA testing is important for the diagnosis of these diseases because clinical discrimination is complicated by their late onset and frequently overlapping symptomatology. However, detection of pathologic alleles expanded up to several thousand trinucleotides poses a challenge for the introduction of rapid, fully automatic, and simple DNA diagnostic procedures. Here we propose a simple two-step polymerase chain reaction (PCR) protocol for rapid molecular diagnostics of myotonic dystrophy, Huntington's disease, and possibly also other triplet expansion diseases. Standard PCR amplification with target repeat flanking primers is used for the detection of alleles of up to 100 repeats; next, triplet-primed PCR is applied for detection of larger expansions. Automated capillary electrophoresis of amplicons allows rapid discrimination between normal, premutated and expanded (CTG/CAG)(n) alleles. Using the suggested protocol, the expanded allele was successfully detected in all test DNA samples with known genotypes. Our experience demonstrates that the suggested two-step PCR protocol provides high sensitivity, specificity, and reproducibility; is significantly less time-consuming; is easier to perform; and provides a better basis for automation than previous methods requiring Southern analysis. Therefore, it can be used for confirmation of uncertain clinical diagnoses, for prenatal testing in at-risk families, and, generally in research on these diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16792511     DOI: 10.1089/gte.2006.10.85

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  11 in total

1.  Triplet Repeat Primed PCR (TP-PCR) in Molecular Diagnostic Testing for Spinocerebellar Ataxia Type 3 (SCA3).

Authors:  Ana Rosa Vieira Melo; Amanda Ramos; Nadiya Kazachkova; Mafalda Raposo; Bruno Filipe Bettencourt; Ana Rita Rendeiro; Teresa Kay; João Vasconcelos; Jácome Bruges-Armas; Manuela Lima
Journal:  Mol Diagn Ther       Date:  2016-12       Impact factor: 4.074

2.  Validation of sensitivity and specificity of tetraplet-primed PCR (TP-PCR) in the molecular diagnosis of myotonic dystrophy type 2 (DM2).

Authors:  Claudio Catalli; Alessandra Morgante; Raniero Iraci; Fabrizio Rinaldi; Annalisa Botta; Giuseppe Novelli
Journal:  J Mol Diagn       Date:  2010-07-08       Impact factor: 5.568

Review 3.  Biomolecular diagnosis of myotonic dystrophy type 2: a challenging approach.

Authors:  Giovanni Meola; Fiammetta Biasini; Rea Valaperta; Elena Costa; Rosanna Cardani
Journal:  J Neurol       Date:  2017-05-26       Impact factor: 4.849

4.  Distribution of CTG repeats at the DMPK gene in myotonic dystrophy patients and healthy individuals from the Mexican population.

Authors:  J J Magaña; P Cortés-Reynosa; R Escobar-Cedillo; R Gómez; N Leyva-García; B Cisneros
Journal:  Mol Biol Rep       Date:  2010-07-16       Impact factor: 2.316

5.  A Study of Triplet-Primed PCR for Identification of CAG Repeat Expansion in the HTT Gene in a Cohort of 503 Indian Cases with Huntington's Disease Symptoms.

Authors:  Pratiksha Chheda; Milind Chanekar; Yogita Salunkhe; Tavisha Dama; Anurita Pais; Shailesh Pande; Rajesh Bendre; Nilesh Shah
Journal:  Mol Diagn Ther       Date:  2018-06       Impact factor: 4.074

6.  High throughput screening for expanded CTG repeats in myotonic dystrophy type 1 using melt curve analysis.

Authors:  Russell J Butterfield; Carina Imburgia; Katie Mayne; Tara Newcomb; Diane M Dunn; Brett Duval; Marcia L Feldkamp; Nicholas E Johnson; Robert B Weiss
Journal:  Mol Genet Genomic Med       Date:  2021-02-24       Impact factor: 2.183

7.  Simple Repeat-Primed PCR Analysis of the Myotonic Dystrophy Type 1 Gene in a Clinical Diagnostics Environment.

Authors:  Philippa A Dryland; Elaine Doherty; Jennifer M Love; Donald R Love
Journal:  J Neurodegener Dis       Date:  2013-11-11

8.  Population-Based Prevalence of Myotonic Dystrophy Type 1 Using Genetic Analysis of Statewide Blood Screening Program.

Authors:  Nicholas E Johnson; Russell J Butterfield; Katie Mayne; Tara Newcomb; Carina Imburgia; Diane Dunn; Brett Duval; Marcia L Feldkamp; Robert B Weiss
Journal:  Neurology       Date:  2021-01-20       Impact factor: 9.910

9.  Comparison of Shear Wave Elastography and Dynamometer Test in Muscle Tissue Characterization for Potential Medical and Sport Application.

Authors:  Peter Soldos; Zsuzsanna Besenyi; Katalin Hideghéty; László Pávics; Ádám Hegedűs; Levente Rácz; Bence Kopper
Journal:  Pathol Oncol Res       Date:  2021-06-29       Impact factor: 3.201

10.  Identification and characterization of DM1 patients by a new diagnostic certified assay: neuromuscular and cardiac assessments.

Authors:  Rea Valaperta; Valeria Sansone; Fortunata Lombardi; Chiara Verdelli; Alessio Colombo; Massimiliano Valisi; Elisa Brigonzi; Elena Costa; Giovanni Meola
Journal:  Biomed Res Int       Date:  2013-05-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.